Drug Profile
KAR-2
Alternative Names: Tubulin-binding bis-indolLatest Information Update: 17 Nov 2003
Price :
$50
*
At a glance
- Originator Gedeon Richter
- Class Antineoplastics; Indoles; Vinca alkaloids
- Mechanism of Action Mitosis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 17 Nov 2003 Discontinued - Preclinical for Cancer in Hungary (unspecified route)
- 08 Mar 1999 Preclinical development for Cancer in Hungary (Unknown route)